tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Stephan, 19 are a HOLD (35.19%), 35 are a BUY (64.81%).
Analyst Thomas Stephan, currently employed at STIFEL, carries an average stock price target met ratio of 68.22% that have a potential upside of 16.62% achieved within 71 days.
Thomas Stephan’s has documented 111 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RXST, Rxsight at 10-Aug-2026.
Analyst best performing recommendations are on RXST (RXSIGHT).
The best stock recommendation documented was for RXST (RXSIGHT) at 8/10/2026. The price target of $7 was fulfilled within 1 day with a profit of $0.43 (6.54%) receiving and performance score of 65.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Oct-2022
$201
$16.47 (8.93%)
$150
Hold Since 30-Jul-2026
$172
$-12.53 (-6.79%)
$72
Buy Since 01-Aug-2024
$215
$30.47 (16.51%)
$180
Buy Since 07-Oct-2025
$188
$3.47 (1.88%)
$175
Buy Since 26-Jun-2023
$190
$5.47 (2.96%)
$175
Which stock is Thomas Stephan is most bullish on?
Which stock is Thomas Stephan is most reserved on?
What Year was the first public recommendation made by Thomas Stephan?
